Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight transactions ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire select ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...

CLEVELAND, Ohio — University Hospitals has sold some of its outpatient laboratory locations to New Jersey-based Quest Diagnostics for an undisclosed amount, Quest announced. The sale ...

Laboratory operator Quest Diagnostics beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its diagnostic tests.

In a separate agreement, Quest will provide lab services for end-stage kidney disease and specialized water testing for Fresenius and its partners.

For University Hospitals' providers and patients using Quest for lab services, Quest's laboratories in Twinsburg, Ohio and Pittsburgh, Pennsylvania will perform the testing. University Hospitals ...

Sonora Quest Laboratories released a Thursday news release promoting a male fertility test men can buy online and take privately at home.

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...